James J. Pallotta Increases Stake in TriSalus Life Sciences to 5.2%

On May 20, 2026, James J. Pallotta filed a Schedule 13G/A with the SEC, reporting a significant increase in his holdings of TriSalus Life Sciences, Inc. (TLSI). As of the event date on May 15, 2026, Pallotta beneficially owns 3,188,711 shares of Common Stock, representing 5.2% of the company's outstanding shares. This position includes 114,268 shares underlying warrants that are currently exercisable. The filing indicates that Pallotta holds sole voting and dispositive power over the entirety of these shares. The ownership percentage was calculated based on 61,416,535 shares outstanding as of May 8, 2026, as reported in the issuer's most recent Quarterly Report. This amendment marks a shift from a 0.0% reported position in previous records to a threshold exceeding 5%. The filing was made under Rule 13d-1(c), certifying that the securities were not acquired for the purpose of influencing or changing the control of the issuer. James J. Pallotta is an individual investor based in Miami Beach, Florida.